Puma Biotechnology Inc. (PBYI) revealed earnings for third quarter that Decreased from the same period last year but beat the Street estimates.
The company's bottom line came in at $8.8 million, or $0.17 per share. This compares with $20.3 million, or $0.41 per share, last year.
Excluding items, Puma Biotechnology Inc. reported adjusted earnings of $10.5 million or $0.21 per share for the period.
Analysts on average had expected the company to earn $0.09 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 32.3% to $54.5 million from $80.5 million last year.
Puma Biotechnology Inc. earnings at a glance (GAAP) :
-Earnings: $8.8 Mln. vs. $20.3 Mln. last year.-EPS: $0.17 vs. $0.41 last year.-Revenue: $54.5 Mln vs. $80.5 Mln last year.
-Guidance:Next quarter revenue guidance: $67- $70 MlnFull year revenue guidance: $220 - $223 Mln
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.